Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adenoviral-based vaccine promotes neoantigen-specific CD8+ T cell stemness and tumor rejection.
D'Alise AM, Brasu N, De Intinis C, Leoni G, Russo V, Langone F, Baev D, Micarelli E, Petiti L, Picelli S, Fakih M, Le DT, Overman MJ, Shields AF, Pedersen KS, Shah MA, Mukherjee S, Faivre T, Delaite P, Scarselli E, Pace L. D'Alise AM, et al. Among authors: shields af. Sci Transl Med. 2022 Aug 10;14(657):eabo7604. doi: 10.1126/scitranslmed.abo7604. Epub 2022 Aug 10. Sci Transl Med. 2022. PMID: 35947675 Free PMC article.
Imaging of cell proliferation: status and prospects.
Bading JR, Shields AF. Bading JR, et al. Among authors: shields af. J Nucl Med. 2008 Jun;49 Suppl 2:64S-80S. doi: 10.2967/jnumed.107.046391. J Nucl Med. 2008. PMID: 18523066 Free article. Review.
PET imaging of proliferation with pyrimidines.
Tehrani OS, Shields AF. Tehrani OS, et al. Among authors: shields af. J Nucl Med. 2013 Jun;54(6):903-12. doi: 10.2967/jnumed.112.112201. Epub 2013 May 14. J Nucl Med. 2013. PMID: 23674576 Free article. Review.
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers.
Khan HY, Nagasaka M, Li Y, Aboukameel A, Uddin MH, Sexton R, Bannoura S, Mzannar Y, Al-Hallak MN, Kim S, Beydoun R, Landesman Y, Mamdani H, Uprety D, Philip PA, Mohammad RM, Shields AF, Azmi AS. Khan HY, et al. Among authors: shields af. Cancer Res Commun. 2022 May;2(5):342-352. doi: 10.1158/2767-9764.crc-21-0176. Epub 2022 May 10. Cancer Res Commun. 2022. PMID: 35573474 Free PMC article.
Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma.
Vaishampayan UN, Heilbrun LK, Shields AF, Lawhorn-Crews J, Baranowski K, Smith D, Flaherty LE. Vaishampayan UN, et al. Among authors: shields af. Invest New Drugs. 2007 Feb;25(1):69-75. doi: 10.1007/s10637-006-9005-8. Epub 2006 Aug 26. Invest New Drugs. 2007. PMID: 16937078 Clinical Trial.
236 results